COVID-19: Clinical Trial Management During the Pandemic
Jyotsana Chaudhary, MSc, Jatin Gupta, MSc and Sukanya Saha, MSc
Note: Given that the situation is continually evolving, the thoughts and opinions are formulated to keep the current situation in mind.
Regulatory agencies across the world are issuing flexible guidelines considering the COVID-19 pandemic. This is a snapshot of the key guidelines issued and the resulting implications on clinical trial sponsors and investigators.